Background: Systemic-sclerosis (SSc) is an autoimmune disease characterized by skin fibrosis. Key players in fibrosis are myofibroblasts (MF) that following TGFb exposure produce collagen-rich extracellular-matrix (fibrotic-ECM). Latent-TGFb is bound to the ECM and is activated by αv integrins. MF express both αvβ3 integrin, a membrane receptor for thyroid hormones (TH=T3/T4) and pro-fibrotic miRNA-21. miRNA-21 promotes deiodinase type-3 expression (DIO3) that degrades T3. T3 attenuates fibrosis. We hypothesized that avb3 through its TH binding site affects the fibrotic processes.
Methods: 1.Dermal-fibroblast (DF) cultured without/with TGFb were removed by a strong base, leaving "normal/fibrotic" ECM in wells, respectively. DF were cultured on those matrices without/with tetraiodothyroacetic-acid (tetrac-an avb3 ligand and T4 antagonist) for 48-72hr, harvested and evaluated for proliferation (cell-count,cyclin-D1), MF pro-fibrotic markers (aSMA, collagen, elastin), αvβ3, miRNA-21 and DIO3 expressions (western-blot,PCR). 2.SSc patients (n=19) were divided into high/low T3 groups and evaluated for circulating miRNA-21 levels.
Results: The "fibrotic-ECM" increased DF proliferation and expression of MF pro-fibrotic markers, avb3, miRNA-21 and DIO3 compared to "normal-ECM" (24-123%↑,p≤0.05). Addition of tetrac to MF downregulated cell proliferation to the control level and pro-fibrotic markers expression (20-47%↓,p≤0.05), compared to cells without tetrac. Furthermore, it reduced αvβ3, miRNA-21 and DIO3 levels (40-50%↓,p≤0.05). Accordingly, reduced miRNA-21 levels were found in the high T3 SSc group, compared to the low T3 group (p≤0.05).
Conclusion:Tetrac has both an anti-fibrotic and inhibitory effect on DIO3 level. This result and the inverse levels of miRNA-21 and T3 in SSc patients suggest that the αvβ3-miRNA-21-DIO3-T3 pathway link between fibrosis and thyroid hormones.